Colorado's Ampio Pharmaceuticals, Inc. Raises $63 Million+

Published: Mar 06, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ampio Pharmaceuticals announced today it has raised net proceeds of $63.3 million following the completion of an underwritten public offering. Ampio (NYSE: AMPE), which is based in Greenwood Village, CO, focuses on developing therapies for inflammatory conditions. Its two most advanced drug candidates are aspartyl-alanyl diketopiperazine (Ampion), which could be used to treat osteoarthritis of the knee, and a reformulation of the generic oral steroid danazol (Optina), a potential treatment for diabetic macular edema, which affects the eye.

Help employers find you! Check out all the jobs and post your resume.

Back to news